文献速递颈动脉与弓上血管

颈动脉内膜切除术价值决定因素的评估

Assessment of Determinants of Value in Carotid Endarterectomy.
PubMed 文献 · Ann Vasc Surg · 2022-09-01

该研究将2014年1月2日至2020年8月28日密歇根州开展血管外科手术医院的Medicare与商业保险CEA住院记录与回顾性临床注册数据链接,按风险校正30天复合并发症与价格标准化总 episode 支付划分低价值与高价值医院。共纳入39家医院6595例患者,低价值医院30天复合并发症更高(17.9% vs 10.1%,P<0.001),平均总 episode 支付也更高(19635美元 vs 15709美元)。作者认为总 episode 支出与手术质量之间似乎几乎没有关系。

要点

  • 低价值医院30天复合并发症17.9% vs 高价值医院10.1%(P<0.001)。
  • 低价值医院平均总 episode 支付19635美元 vs 高价值医院15709美元。
  • 仅纳入未发生并发症患者时结果相似。

核心结论

  • 各医院CEA的质量与支付存在巨大差异。
  • 低价值医院费用更高且独立于术后并发症。
  • 总 episode 支出与手术质量之间似乎几乎没有关系,提示通过降低总 episode 成本而不影响手术结局来改善价值或许是可能的。

研究设计与样本

  • 回顾性队列研究,将2014年1月2日至2020年8月28日Medicare与商业保险CEA住院记录链接至密歇根州开展血管外科手术医院的回顾性临床注册数据。
  • 共纳入39家医院6595例患者。
  • 以医院层面风险校正30天复合并发症与30天风险校正价格标准化总 episode 支付的交集划分低价值与高价值医院。

主要发现

  • 低价值医院30天复合并发症发生率高于高价值医院(17.9% vs 10.1%,P<0.001)。
  • 低价值医院再手术率高于高价值医院(3.0% vs 1.4%,P=0.016),再入院率高于高价值医院(10.7% vs 6.2%,P=0.012),新发神经功能缺损率高于高价值医院(4.6% vs 2.3%,P=0.017),死亡率高于高价值医院(1.6% vs 0.6%,P<0.049)。
  • 低价值医院平均总 episode 支付为19635美元,高价值医院为15709美元,差异来自指数住院(10800美元 vs 9587美元,P=0.002)、专业费用(3421美元 vs 2827美元,P<0.001)、再入院费用(3011美元 vs 1826美元,P<0.001)与急性期后照护费用(2335美元 vs 1486美元,P<0.001)。
  • 仅纳入未发生并发症的患者时结果相似。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Over 150,000 carotid endarterectomies (CEA) are performed annually worldwide, accounting for $900 million in the United States alone. How cost/spending and quality are related is not well understood but remain essential components in maximizing value. We sought to identify determinants of variability in hospital 90-day episode value for CEA. METHODS: Medicare and private-payer admissions for CEA from January 2, 2014 to August 28, 2020 were linked to retrospective clinical registry data for hospitals in Michigan performing vascular surgery. Hospital-specific, risk-adjusted, 30-day composite complications (defined as reoperation, new neurologic deficit, myocardial infarction, additional procedure including CEA or carotid artery stenting, readmission, or mortality) and 30-day risk-adjusted, price-standardized total episode payments were used to categorize hospitals into low or high value by defining the intersection between complications and spending. RESULTS: A total of 6,595 patients across 39 hospitals were identified across both datasets. Patients at low-value hospitals had a higher rate of 30-day composite complications (17.9% vs. 10.1%, P < 0.001) driven by a significantly higher rate of reoperation (3.0% vs. 1.4%, P = 0.016), readmission (10.7% vs. 6.2%, P = 0.012), new neurologic deficit (4.6% vs. 2.3%, P = 0.017), and mortality (1.6% vs. 0.6%, P < 0.049). Mean total episode payments were $19,635 at low-value hospitals compared to $15,709 at high-value hospitals driven by index hospitalization ($10,800 vs. $9,587, P = 0.002), professional ($3,421 vs. $2,827, P < 0.001), readmission ($3,011 vs. $1,826, P < 0.001), and post-acute care payments ($2,335 vs. $1,486, P < 0.001). Findings were similar when only including patients who did not suffer a complication. CONCLUSIONS: There is tremendous variation in both quality and payments across hospitals included for CEA. Importantly, costs were higher at low-value hospitals independent of postoperative complication. There appears to be little to no relationship between total episode spending and surgical quality, suggesting that improvements in value may be possible by decreasing total episode cost without affecting surgical outcomes.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Brown CS, Osborne NH, Hider A, et al. Assessment of Determinants of Value in Carotid Endarterectomy. Ann Vasc Surg. 2022. PMID: 36058455. doi:10.1016/j.avsg.2022.08.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。